Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
fluorouracil (efudex) (1 trial)
irinotecan (Camptosar) (1 trial)
leucovorin (1 trial)
ocz103-os (1 trial)
oxaliplatin (eloxatin) (1 trial)
Colorectal Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (5 total)